1. Lou, Yuqing, Xu, Jianlin, Zhang, Yanwei, Lu, Jun, Han, Baohui. 2021. Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis. In Cell death & disease, 12, 170. doi:10.1038/s41419-021-03439-8. https://pubmed.ncbi.nlm.nih.gov/33568630/
2. Parajuli, Keshab Raj, Jung, Younghun, Taichman, Russell S. 2024. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells. In Oncology reports, 51, . doi:10.3892/or.2024.8698. https://pubmed.ncbi.nlm.nih.gov/38624012/
3. Dutta, Debapriya, Lai, Kuan-Yu, Reyes-Ordoñez, Adriana, Chen, Jie, van der Donk, Wilfred A. 2018. Lanthionine synthetase C-like protein 2 (LanCL2) is important for adipogenic differentiation. In Journal of lipid research, 59, 1433-1445. doi:10.1194/jlr.M085274. https://pubmed.ncbi.nlm.nih.gov/29880530/
4. Maixner, Dylan W, Christy, David, Kong, Lingwei, Hooks, Shelley B, Weng, Han-Rong. . Phytohormone abscisic acid ameliorates neuropathic pain via regulating LANCL2 protein abundance and glial activation at the spinal cord. In Molecular pain, 18, 17448069221107781. doi:10.1177/17448069221107781. https://pubmed.ncbi.nlm.nih.gov/35647699/
5. Zhao, Hua-Fu, Zhou, Xiu-Ming, Wang, Jing, Huang, Guo-Dong, Li, Wei-Ping. 2021. Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients. In Journal of translational medicine, 19, 372. doi:10.1186/s12967-021-02979-z. https://pubmed.ncbi.nlm.nih.gov/34461927/
6. Leber, Andrew, Hontecillas, Raquel, Tubau-Juni, Nuria, Fitch, Sarah N, Bassaganya-Riera, Josep. . Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus. In Journal of immunology (Baltimore, Md. : 1950), 213, 1429-1440. doi:10.4049/jimmunol.2400127. https://pubmed.ncbi.nlm.nih.gov/39365106/
智鼠故事 
